drugset / Trial / NCT01610050
A Phase I Study of LFA102 in Japanese Patients
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study will evaluate safety and tolerability to determine the MTD/RD.
Timeline
- Start
- 2012-06
- Primary completion
- 2014-02
- Completion
- 2014-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LFA102 | Monoclonal antibody | — | Intravenous |